Skip to main content

Advertisement

SpringerLink
Log in

Is the Dialysate Calcium Concentration of 1.75 mmol/L Suitable for Chinese Patients on Maintenance Hemodialysis?

  • Original Research
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

We studied the effects of increasing the dialysate calcium concentration (DCa) to 1.75 mmol/L on controlling chronic kidney disease–mineral and bone disorder in Chinese patients on maintenance hemodialysis (MHD). We reviewed the data of MHD patients in one center (cohort 1) during prior 10 years and analyzed the risk factors of mortality and transference calcification (TC) in120 MHD patients surviving in 2003 (cohort 2). A multicenter, prospective, parallel-group, controlled trial (cohort 3) was also conducted from January 2011 to December 2012. The DCa at one center was increased from 1.5 to 1.75 mmol/L but was not changed at the other two centers. The clinical outcomes, biochemical parameters, medicine treatments, and TC markers [aortic arch calcification score (AoACS)] were compared between groups. In cohort 1, the annual mean serum iPTH increased significantly over 10 years. In cohort 1, 72 patients survived for 10 years, whose doses of calcium salts and active vitamin D3 and AoACs increased progressively. In cohort 2, the main cause of death was cardiocerebrovascular disease (CCVD) (n = 18, 48.6 %). Male sex and lower serum calcium concentrations were independent risk factors for CCVD mortality. In cohort 3, serum phosphorus, iPTH, and 25(OH)D decreased and serum calcium increased significantly; also, the doses of calcium and vitamin D3 decreased from 2011 to 2012 in the DCa 1.75 group. There were no significant differences in clinical outcomes either between groups or between the two calendar years. Our results indicate that increasing DCa to 1.75 mmol/L can decrease the elevated levels of serum iPTH and phosphorus, reduce the doses of calcium and vitamin D3, and be safe for short periods of time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jadoul M, Albert JM, Akiba T et al (2006) Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int 70:1358–1366

    Article  CAS  PubMed  Google Scholar 

  2. Block GA, Klassen PS, Lazarus JM et al (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208–2218

    Article  CAS  PubMed  Google Scholar 

  3. Kalantar-Zadeh K, Kuwae N, Regidor DL et al (2006) Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70:771–780

    Article  CAS  PubMed  Google Scholar 

  4. Tentori F, Blayney MJ, Albert JM et al (2008) Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 52:519–530

    Article  CAS  PubMed  Google Scholar 

  5. Floege J, Kim J, Ireland E et al (2011) Serum iPTH, calcium and phosphate, and the risk of mortality in a European hemodialysis population. Nephrol Dial Transpl 26(6):1948–1955

    Article  CAS  Google Scholar 

  6. Goodman WG, Goldin J, Kuizon BD et al (2000) Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478–1483

    Article  CAS  PubMed  Google Scholar 

  7. Raggi P, Boulay A, Chasan-Taber S et al (2002) Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39:695–701

    Article  PubMed  Google Scholar 

  8. National Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(Suppl 3):S1–S202

    Google Scholar 

  9. Guideline Working Group, Japanese Society for Dialysis Therapy (2008) Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients. Ther Apher Dial 12:514–525

    Article  Google Scholar 

  10. Kidney Disease: Improving Global Outcomes (KDIGO) CKD–MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD–MBD). Kidney Int 76(Suppl 113):S1–S130

    Google Scholar 

  11. Lezaic V, Pejanovic S, Kostic S et al (2007) Effects of lowering dialysate calcium concentration on mineral metabolism and parathyroid hormone secretion: a multicentric study. Ther Apher Dial 11:121–130

    Article  CAS  PubMed  Google Scholar 

  12. Spasovski G, Gelev S, Masin-Spasovska J et al (2007) Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium. Bone 41:698–703

    Article  CAS  PubMed  Google Scholar 

  13. Toussaint N, Cooney P, Kerr PG (2006) Review of dialysate calcium concentration in hemodialysis. Hemodial Int 10:326–337

    Article  PubMed  Google Scholar 

  14. Beijing Hemodialysis Record Data System (2011) 2010 Annual report on hemodialysis in Beijing. Chin J Blood Purif 10:19–21

    Google Scholar 

  15. Ogawa T, Ishida H, Matsuda N et al (2009) Simple evaluation of aortic arch calcification by chest radiography in hemodialysis patients. Hemodial Int 13:301–306

    Article  PubMed  Google Scholar 

  16. Dialysis Outcomes and Practice Patterns Study (2010) DOPPS annual report. http://www.dopps.org/annualreport/index.htm. Accessed 23 Feb 2013

  17. Hwang JC, Chen CA, Wang CT et al (2008) Long-term effect of different dialysate calcium concentrations on parathyroid hormone levels in hemodialysis patients. Ren Fail 30(10):943–949

    Article  CAS  PubMed  Google Scholar 

  18. Gabutti L, Bianchi G, Soldini D et al (2009) Haemodialysis consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids. Nephrol Dial Transpl 24(2):973–981

    CAS  Google Scholar 

  19. Al-Hejaili F, Kortas C, Leitch R et al (2003) Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration. J Am Soc Nephrol 14:2322–2328

    Article  CAS  PubMed  Google Scholar 

  20. Asci G, Ok E, Savas R et al (2011) The link between bone and coronary calcifications in CKD-5 patients on haemodialysis. Nephrol Dial Transpl 26:1010–1015

    Article  Google Scholar 

  21. West SL, Swan VJ, Jamal SA (2008) Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population. Clin J Am Soc Nephrol 5(Suppl 1):S41–S47

    Google Scholar 

  22. Yamada K, Fujimoto S, Nishiura R et al (2007) Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis. Nephrol Dial Transpl 22:2032–2037

    Article  Google Scholar 

  23. Dabrowski J, Stazka J, Janicka L et al (2004) Calcification of heart valves in hemodialyzed patients and their cardiosurgical correction. Kardiol Pol 61(8):151–155

    PubMed  Google Scholar 

  24. Kim J-K, Moon SJ, Park HC et al (2011) Effects of lowering dialysate calcium concentrations on arterial stiffness in patients undergoing hemodialysis. Korean J Intern Med 26:320–327

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. LeBeouf A, Mac-Way F, Utescu MS et al (2009) Effects of acute variation of dialysate calcium concentrations on arterial stiffness and aortic pressure waveform. Nephrol Dial Transpl 24(2):3788–3794

    Article  CAS  Google Scholar 

  26. Goodkin DA, Bragg-Gresham JL, Koenig KG et al (2003) Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 10:3270–3277

    Article  Google Scholar 

  27. Hou F, Jiang J, Chen J et al (2012) China collaborative study on dialysis: a multi-center cohort study on cardiovascular diseases in patients on maintenance dialysis. BMC Nephrol 13:94–102

    Article  PubMed Central  PubMed  Google Scholar 

  28. Floege J, Kim J, Ireland E et al (2011) Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transpl 26:1948–1955

    Article  CAS  Google Scholar 

  29. Joosen IA, Schiphof F, Versteylen MO et al (2012) Relation between mild to moderate chronic kidney disease and coronary artery disease determined with coronary CT angiography. PLoS One 7(10):e47267

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Lee MJ, Shin DH, Kim SJ et al (2012) Progression of aortic arch calcification over 1 year is an independent predictor of mortality in incident peritoneal dialysis patients. PLoS One 7(11):e48793

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. Markaki A, Kyriazis J, Stylianou K et al (2012) The role of serum magnesium and calcium on the association between adiponectin levels and all-cause mortality in end-stage renal disease patients. PLoS One 7(12):e52350

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Jean G, Lataillade D, Genet L et al (2013) Higher dialysate calcium is not associated with mortality in hemodialysis patients: results from the French ARNOS study [in French]. Nephrol Ther 9:103–107

    Article  PubMed  Google Scholar 

  33. Sigrist MK, Taal MW, Bungay P et al (2007) Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol 2:1241–1248

    Article  CAS  PubMed  Google Scholar 

  34. Kim HG, Song SW, Kim TY et al (2011) Risk factors for progression of aortic arch calcification in patients on maintenance hemodialysis and peritoneal dialysis. Hemodial Int 15:460–467

    Article  PubMed  Google Scholar 

  35. Pencak P, Czerwieńska B, Ficek R et al (2013) Calcification of coronary arteries and abdominal aorta in relation to traditional and novel risk factors of atherosclerosis in hemodialysis patients. BMC Nephrol 14:10–18

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Coen G, Pierantozzi A, Spizzichino D et al (2010) Risk factors of one year increment of coronary calcifications and survival in hemodialysis patients. BMC Nephrol 11:10–18

    Article  PubMed Central  PubMed  Google Scholar 

  37. Dukkipati R, Kovesdy CP, Kim Y et al (2010) Association of relatively low serum parathyroid hormone with malnutrition–inflammation complex and survival in maintenance hemodialysis patients. J Ren Nutr 20(4):243–254

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Kong X, Zhang L, Zhang L et al (2012) Mineral and bone disorder in Chinese dialysis patients: a multicenter study. BMC Nephrol 13:116–123

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  39. Beijing Dialysis and Transplantation Registration Group (2001) The report about the registration of dialysis and transplantation in Beijing 1999. Chin J Nephrol 17(2):79–82

    Google Scholar 

  40. US Renal Data System (2012) Atlas of ESRD 2010. http://www.usrds.org/2012/view/v2_05.aspx. Accessed 23 Feb 2013

  41. Seyffart G, Schulz T, Stiller S (2009) Use of two calcium concentrations in hemodialysis—report of a 20-year clinical experience. Clin Nephrol 71(3):296–305

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This project was supported by the Capital Health Research and Development Project (2011-2002-02), the Beijing Municipal Science and Technology Commission Funds (Z121107001012138), and the Beijing Natural Science Foundation (7132091).

Author information

Authors and Affiliations

  1. Nephrology Faculty, Beijing Friendship Hospital, Capital Medical University, No. 95 Yong-An Street, Xi-Cheng District, Beijing, 100050, China

    Dong-liang Zhang, Li-yan Wang, Sha Liu & Wen-hu Liu

  2. Nephrology Faculty, Beijing ChaoYang Hospital, Capital Medical University, Beijing, China

    Fang Sun, Yi-lun Zhou & Tai-gen Cui

  3. Nephrology Faculty, Beijing FuXing Hospital, Capital Medical University, Beijing, China

    Xiao-feng Duan & Yi Sun

Authors
  1. Dong-liang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Li-yan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fang Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yi-lun Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiao-feng Duan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sha Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yi Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tai-gen Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Wen-hu Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wen-hu Liu.

Additional information

The authors have stated that they have no conflict of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 672 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, Dl., Wang, Ly., Sun, F. et al. Is the Dialysate Calcium Concentration of 1.75 mmol/L Suitable for Chinese Patients on Maintenance Hemodialysis?. Calcif Tissue Int 94, 301–310 (2014). https://doi.org/10.1007/s00223-013-9811-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-013-9811-x

Keywords

Search

Navigation